Biomarker ID 2485 |
| Detailed information | |
|---|---|
| CancerLivER ID | 2485 |
| Biomarker | IGFBP3, c-fos, p21 |
| Biomarker Name/Symbol (given in Publication) | IGFBP3, c-fos and p21 |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential Diagnostic marker for HCC and validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Differentially expressed between HCC and non-tumor liver tissue |
| Level of significance | p < 0.01 |
| Source | Tissue |
| PMID | 14642619 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | Training dataset: 68 non-B, non-C liver samples, including 20 T and 17 NT samples, that were obtained from non-B, non-C HCC patients, and 31 N samples from metastatic liver cancer patients; Validation dataset: 37 non-B, non-C liver tissues (20 HCC, 17 non-tumor liver) from 20 patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2003 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |